QuidelOrtho
QDEL
#4767
Rank
C$2.63 B
Marketcap
C$38.75
Share price
-0.22%
Change (1 day)
-26.50%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.

EPS for QuidelOrtho (QDEL)

EPS in 2025 (TTM): C-$23.68

According to QuidelOrtho's latest financial reports the company's current EPS (TTM) is C-$23.76. In 2024 the company made an earnings per share (EPS) of C-$42.27 a decrease over its 2023 EPS that were of C-$0.22.

EPS history for QuidelOrtho from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$23.68-43.97%
2024C-$42.2718825%
2023C-$0.22-101.27%
2022C$17.56-25.12%
2021C$23.45-12.64%
2020C$26.84980.34%
2019C$2.48-10.1%
2018C$2.76-960.87%
2017C-$0.32
2015C-$0.24-15%
2014C-$0.28-190.91%
2013C$0.3146.67%
2012C$0.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Meridian Bioscience
VIVO
C$1.35-105.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
C$7.78-132.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$24.21-201.88%๐Ÿ‡บ๐Ÿ‡ธ USA
OraSure Technologies
OSUR
C-$1.12-95.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
C$6.81-128.67%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
C$10.75-145.24%๐Ÿ‡บ๐Ÿ‡ธ USA